Navigating the landscape of terminal care and access to medications like Pentobarbital in New South Wales, the state, requires a careful grasp of the complex legal structure. Currently, this powerful sedative does not have a approved place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not routinely prescribed by healthcare pro